Logistical Considerations with Anti-VEGF Treatment in Wet AMD
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Katharine Talcott, MD
Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
Maria H. Berrocal, MD
Avni P. Finn, MD, MBA
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Danny Mammo, MD
Redefining The Cash-Pay Model in Modern Optometric Practice
Jason E. Compton, OD, FAAO
Elevating Clinical Efficiency
Diana Chu
Practice Efficiency and Innovation
Jacob Lang
Strategies for Addressing Complications in Retinal Vein Occlusion
Lisa Schocket, MD
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Houman Hemmati, MD, PhD
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.